Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT

User menu

Search

  • Advanced search
eNeuro
eNeuro

Advanced Search

 

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Blog
    • Collections
    • Podcast
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • ABOUT
    • Overview
    • Editorial Board
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SUBMIT
PreviousNext
Research ArticleNew Research, Disorders of the Nervous System

Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence

Daniel Hoops, Lauren M. Reynolds, Jose-Maria Restrepo-Lozano and Cecilia Flores
eNeuro 9 January 2018, 5 (1) ENEURO.0372-17.2017; https://doi.org/10.1523/ENEURO.0372-17.2017
Daniel Hoops
1Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Quebec H4H 1R3, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniel Hoops
Lauren M. Reynolds
1Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Quebec H4H 1R3, Canada
2Integrated Program in Neuroscience, McGill University, Montreal, Quebec H3A 1A1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lauren M. Reynolds
Jose-Maria Restrepo-Lozano
1Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Quebec H4H 1R3, Canada
2Integrated Program in Neuroscience, McGill University, Montreal, Quebec H3A 1A1, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilia Flores
1Department of Psychiatry, Douglas Mental Health University Institute, McGill University, Montreal, Quebec H4H 1R3, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Cecilia Flores
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Correction: Hoops et al., Dopamine Development in the Mouse Orbital Prefrontal Cortex is Protracted and Sensitive to Amphetamine in Adolescence (eNeuro January/February 2018, 5(1) e0372-17.2017 1-9 https://doi.org/10.1523/ENEURO.0372-17.2017 - February 26, 2018

Abstract

The prefrontal cortex (PFC) is divided into subregions, including the medial and orbital prefrontal cortices. Dopamine connectivity in the medial PFC (mPFC) continues to be established throughout adolescence as the result of the continuous growth of axons that innervated the nucleus accumbens (NAcc) prior to adolescence. During this period, dopamine axons remain vulnerable to environmental influences, such as drugs used recreationally by humans. The developmental trajectory of the orbital prefrontal dopamine innervation remains almost completely unstudied. Nonetheless, the orbital PFC (oPFC) is critical for some of the most complex functions of the PFC and is disrupted by drugs of abuse, both in adolescent humans and rodents. Here, we use quantitative neuroanatomy, axon-initiated viral-vector recombination, and pharmacology in mice to determine the spatiotemporal development of the dopamine innervation to the oPFC and its vulnerability to amphetamine in adolescence. We find that dopamine innervation to the oPFC also continues to increase during adolescence and that this increase is due to the growth of new dopamine axons to this region. Furthermore, amphetamine in adolescence dramatically reduces the number of presynaptic sites on oPFC dopamine axons. In contrast, dopamine innervation to the piriform cortex is not protracted across adolescence and is not impacted by amphetamine exposure during adolescence, indicating that dopamine development during adolescence is a uniquely prefrontal phenomenon. This renders these fibers, and the PFC in general, particularly vulnerable to environmental risk factors during adolescence, such as recreational drug use.

  • drug use
  • guidance cue
  • orbitofrontal cortex
  • piriform cortex

Significance Statement

Dopamine function in the orbital prefrontal cortex (oPFC) underlies many complex cognitive tasks and is disrupted by drugs of abuse. However, the developmental trajectory of the dopamine innervation to this portion of the PFC remains almost completely unstudied. We show that dopamine axons continue to innervate the oPFC during adolescence. This renders these axons particularly vulnerable to environmental influences. Exposure to amphetamine, at doses equivalent to those used recreationally by adolescent people, reduces the number of dopamine connections in the oPFC. This effect is selective; it also occurs in the medial PFC (mPFC) but not in the piriform cortex. The impact of amphetamine on cortical dopamine development in adolescence appears to be a uniquely prefrontal phenomenon.

Introduction

The prefrontal cortex (PFC) is one of the last brain regions to mature, with changes in structure and connectivity continuing through adolescence and into early adulthood (Paus, 2005; Casey et al., 2008; Caballero et al., 2016). In parallel with these changes, higher order cognitive process that depend on PFC function are also maturing (Sturman and Moghaddam, 2011; Luna et al., 2015; Doremus-Fitzwater and Spear, 2016). Because the function of the PFC is profoundly influenced by the dopamine innervation it receives (Ranganath and Jacob, 2016; Hoops and Flores, 2017), mesocortical dopamine development is an important component of this maturational process. However, the PFC is separated into distinct anatomic regions with distinct functions (Kolb, 2006; Fuster, 2015; Gourley and Taylor, 2016) and our understanding of PFC dopamine development is almost entirely restricted to its medial region (mPFC).

Dopamine connectivity in the mPFC continues to be established throughout adolescence and into early adulthood in both rodents and primates (Kalsbeek et al., 1988; Rosenberg and Lewis, 1995; Benes et al., 2000; Manitt et al., 2011; Naneix et al., 2012; Willing et al., 2017). In mice, the protracted development of the dopamine input to the mPFC results from the ongoing growth of dopamine axons during adolescence (Reynolds et al., 2017). These axons innervate the nucleus accumbens (NAcc) at the onset of adolescence and grow out of the NAcc during the adolescent period. They are uniquely vulnerable to environmental influences during adolescence and exposure to stimulant drugs alters their development, in part by denuding them of presynaptic sites (Reynolds et al., 2015). These alterations result in persistent cognitive changes in adulthood (Reynolds et al., 2015; see also Ye et al., 2014; Kang et al., 2016).

Whether the dopamine innervation to the orbital PFC (oPFC) also continues through adolescence remains understudied (but see Kalsbeek et al., 1988). In rodents and primates, the oPFC plays a central role in some of the most complex cognitive functions of the PFC, including decision-making, cognitive control, and sociality (Bari and Robbins, 2013; Pellis and Pellis, 2013; Wilson et al., 2014). Furthermore, exposure to stimulant drugs alters the structure and function of the oPFC, impacting associated behaviors (Schoenbaum et al., 2006; Goldstein and Volkow, 2011).

There is a longstanding controversy surrounding the designation of the PFC in the rodent and whether it is truly homologous to the PFC in the primate (Preuss, 1995; Uylings et al., 2003; Kolb, 2006; Wise, 2008; Carlén, 2017). However, many characteristics of the PFC important to this study, such as its adolescent maturation (Paus, 2005; Casey et al., 2008; Caballero et al., 2016) and the corresponding changes in cognition and behavior (Sturman and Moghaddam, 2011; Luna et al., 2015; Doremus-Fitzwater and Spear, 2016), are shared between rodents and primates. Furthermore, recent literature supports the hypothesis that the oPFC in particular is homologous between primates and rodents (Heilbronner et al., 2016; Izquierdo, 2017).

In this study, we first characterized the adolescent dopamine innervation to the oPFC in mice. We then examined whether exposure to amphetamine in adolescence affects oPFC dopamine development. To determine if the adolescent trajectory of the dopamine innervation to the PFC is unique, we conducted parallel studies in the adjacent piriform cortex, which is not part of the PFC.

Materials and Methods

Animals

Experiments and procedures were performed in accordance with the guidelines of the McGill University animal care committee’s regulations. Mice were received from Charles River Canada and housed with same-sex littermates at the McGill University Neurophenotyping Center on a 12/12 h light/dark cycle with ad libitum access to food and water. In this study we define “early adolescence” in C57/BL6 mice as between the weaning day [postnatal day (PND)21] and PND32 (Hoops and Flores, 2017). Male mice were used for all experiments.

Drug administration

D-amphetamine sulfate (amphetamine; Sigma-Aldrich) was dissolved in 0.9% saline. Mice were assigned to “drug” and “saline” groups and received one injection of either amphetamine (dose: 4 mg/kg) or saline via intraperitoneal injection once every other day for a total of five injections. This treatment regimen was administered during early adolescence, commencing on PND22 ± 1 and terminating on PND31 ± 1. This regiment has previously been shown to alter mPFC development when administered in early adolescence but not adulthood (Reynolds et al., 2015).

We chose a dose of amphetamine that would achieve a blood plasma concentration in rodents (Riffee et al., 1978; Feldpausch et al., 1998; Van Swearingen et al., 2013) within the range of plasma levels achieved by recreational intake of amphetamine in human adolescents (Kramer et al., 1967; Änggård et al., 1970; Änggård et al., 1970; Gustavsen et al., 2006). Blood plasma concentrations of a lipophilic drug in humans and rodents are likely to result in similar drug concentrations in the brain (Kuczenski and Segal, 2005).

Tissue processing

Mice were euthanized with an intraperitoneal injection of 50 mg/kg ketamine, 5 mg/kg xylazine, and 1 mg/kg acepromazine. They were then perfused intracardially with 10 IU/ml heparinized saline followed by 4% paraformaldehyde. Both perfused solutions were pH adjusted to between 7.2 and 7.4 with dilute hydrochloric acid and sodium hydroxide. After perfusion, brains were dissected from the skull, placed in 4% paraformaldehyde overnight at 4°C, and then stored in phosphate-buffered saline at 4°C. After up to 2 d in storage, brains were cut coronally into 35-μm-thick sections on a vibratome.

Every second section was processed for immunofluorescence. A polyclonal rabbit anti-tyrosine hydroxylase (TH; a commonly used marker for dopamine) antibody (Millipore product #AB152, RRID #AB_390204, 1:1000 dilution) and an Alexa Fluor 594-conjugated polyclonal donkey anti-rabbit antibody (The Jackson Laboratory product #711585152, RRID #AB_2340621, 1:500 dilution) were used as primary and secondary antibodies. The manufacturer’s certificate of analysis reports that the immunogen for the primary antibody is denatured TH from rat pheochromocytoma. Its specificity has been verified by Western blotting (Millipore) and immunoprecipitation (Haycock, 1987). The fibers labeled by this antibody show features indistinguishable from the classic features of cortical dopamine axons in rodents (Berger et al., 1974, 1983; Van Eden et al., 1987; Manitt et al., 2011), namely they are thin fibers with irregularly-spaced varicosities, increase in density toward the deep cortical layers, and are not regularly oriented in relation to the pial surface. This is in contrast to rodent norepinephrine fibers, which are smooth or beaded in appearance, relatively thick with regularly spaced varicosities, increase in density toward the shallow cortical layers, and are in large part oriented either parallel or perpendicular to the pial surface (Berger et al., 1974, 1983; Levitt and Moore, 1979; Miner et al., 2003). Furthermore, previous studies in rodents have noted that only norepinephrine cell bodies are detectable using immunofluorescence for TH, not norepinephrine processes (Pickel et al., 1975; Verney et al., 1982; Miner et al., 2003), and we did not observe any norepinephrine-like fibers. After immunofluorescence staining, sections were mounted onto gel-coated slides and cover-slipped with a DAPI-containing hardset mounting medium (product #H1500, Vector Laboratories).

Axon tracking

To prove conclusively that the protracted dopamine innervation to the oPFC during adolescence is due to new axon growth and not the branching of fibers that reached the oPFC earlier in life, we adapted an axon-initiated viral transduction technique (Beier et al., 2015) to track the growth of dopamine axons in adolescent mice. Briefly, at PND22 a retrogradely transported virus expressing Cre recombinase (CAV-Cre BioCampus Montpellier; Bru et al., 2010) was injected unilaterally at the level of the NAcc. A Cre-dependent enhanced yellow fluorescent protein (eYFP) virus DIO-eYFP (pAAV-Ef1a-DIO-EYFP-WPRE-pA, UNC Vector Core) was simultaneously injected into the ipsilateral ventral tegmental area. CAV-Cre requires the coxsackievirus adenovirus receptor to be taken up and is therefore preferentially taken up by axon terminals (Bru et al., 2010). This recombination strategy limits eYFP labeling to ventral tegmental area neurons with axons that terminate in the NAcc at PND22. Dopamine axons that continue to grow from the NAcc to the oPFC in adolescence can be detected in adulthood by stereologically counting eYFP-expressing dopamine varicosities in the oPFC. To rule out the possibility of detecting dopamine axons in the NAcc that send collaterals to the oPFC, identical dual viral injections were performed in three adult mice, and we counted eYFP-expressing dopamine varicosities in the oPFC three months later. It is important to note that this virally-mediated axon-tracking technique only infects a small percentage of ventral tegmental area neurons that innervate the NAcc (Beier et al., 2015). Therefore, the number of TH-immunolabelled (TH+) varicosities in the adult oPFC that also express eYFP (eYFP+) is an underestimation of the total population of dopamine varicosities on axons that have grown to the oPFC during adolescence.

Stereotaxic surgery

Early adolescent (PND22 ± 1) wild-type mice were anesthetized with isoflurane. Simultaneous unilateral stereotaxic infusions of DIO-eYFP into the VTA and CAV-Cre into the NAcc were performed using Hamilton syringe needles. Coordinates were previously verified by viral and/or dye injection (Manitt et al., 2013; Reynolds et al., 2017). The coordinates we used were: VTA: -2.56 mm (anterior/posterior), +0.9 mm (lateral), and -4.1 mm (dorsal/ventral) relative to bregma, at a 10° angle; and NAcc: +2.6 mm (anterior/posterior), +1.5 mm (lateral), and -3.75 mm (dorsal/ventral) relative to bregma, at a 30° angle. A total of 0.5 μl of purified virus was delivered over an 8-min period followed by a pause of 6 min. Adult (PND75 ± 15) wild-type mice underwent the same injection procedure using the following coordinates: VTA: -3.2 mm (anterior/posterior), +1.0 mm (lateral), and -4.6 mm (dorsal/ventral) relative to bregma, at a 10° angle; NAcc: +1.8 mm (anterior/posterior), +3.0 mm (lateral), and -4.8 mm (dorsal/ventral) relative to bregma, at a 30° angle (Manitt et al., 2013; Daubaras et al., 2014). Carpofen was delivered subcutaneously during surgery and as a diet supplement (MediGel CPF, Clear H2O) throughout recovery for pain management.

Stereological analyses

Contours of oPFC subregions and the piriform cortex were delineated on sections corresponding to plates 14–20 of the mouse brain atlas, resulting in delineations on five sections per region per mouse (Paxinos and Franklin, 2013). We delineated four oPFC subregions: the dorsal agranular insular PFC (daiPFC), the ventral agranular insular PFC (vaiPFC), the lateral oPFC (loPFC), and the ventral oPFC (voPFC) using landmarks derived from Paxinos and Franklin (2013). While the oPFC is present at more anterior levels of the mouse brain, dopamine innervation at these levels is practically absent. The medial subregion of the oPFC is only present at these anterior levels and therefore is not included in our study.

Previous work in the mPFC that uses similar methods delineates only the dense dopamine innervation present in the deep cortical layers (Manitt et al., 2011, 2013; Reynolds et al., 2015). However, the dopamine innervation to the oPFC is diffuse compared to the mPFC and no clearly demarcated area of dopamine innervation is present. Therefore, in this study we only estimate the density of dopamine varicosities within each oPFC subregion; we did not measure the span of the dopamine innervation as we have done previously (Manitt et al., 2011, 2013).

Each cortical subregion was traced at x 5 magnification with a Leica DM400B microscope and Stereoinvestigator software (MicroBrightField). To estimate the number of labeled varicosities, we used the optical fractionator probe function of Stereoinvestigator. We counted TH+ and eYFP+ varicosities, as well as double-labeled varicosities, as appropriate for each experiment. Varicosities were defined as dilated elements associated with axonal processes and were thus only counted if they were clearly associated with an axon (Parish et al., 2002; Manitt et al., 2011). A grid of 175 μm2 was superimposed on each contour, starting at a random point within the contour. Unbiased counting frames (25 μm2) were placed in the top left corner of each grid square. Depending on the area of the region of interest, between 10 and 35 counting frames were quantified per delineation. Counting was conducted at 100× magnification on every other mounted section using a counting depth of 10 μm and a guard zone of 5 μm. Section thickness was measured while counting and counts were performed blind by a single individual. To assess the volume of each delineated region we used the Cavalieri volume estimation method in Stereoinvestigator, with a grid of 100 μm2. To calculate varicosity density for each region of interest in each brain, we divided the total varicosity estimates obtained using the optical fractionator by the estimated volume obtained using the Cavalieri estimator.

Varicosities were used as the counting unit to obtain a measure of dopamine presynaptic density because nearly every dopamine varicosity in the PFC forms a synapse (Séguéla et al., 1988). Varicosities also represent sites where neurotransmitter synthesis, packaging, release, and reuptake most often occur (Benes et al., 1996). As is standard practice for our group, we obtained counts only from the right hemisphere.

Statistical analyses

To analyze varicosity density, we conducted two-way mixed ANOVAs with oPFC subregion and either age (adolescent and adult, result 3.1) or treatment (saline or amphetamine, result 3.3) as fixed factors, mouse as the random factor, and varicosity density as the response variable. Each age and treatment group had a sample size of four mice. Subsequently, we conducted Student’s t tests, corrected for multiple comparisons using the Hochberg-Bonferroni procedure (Hochberg, 1988), between treatment groups separately for each oPFC subregion in all cases where either subregion or the interaction term was significant in the ANOVA. We analyzed data for the piriform cortex independently using Student’s t tests. All data used in this study are available as extended data.

Extended Data Legends

Extended Data Figure 1-1. Dopamine (TH-immunopositive) varicosity density estimates for four subregions of the oPFC in adult and early adolescent mice. Varicosity density was estimated by combining the optical fractionator and Cavelieri estimator methods of the software program Stereoinvestigator (see Materials and Methods). These data were used to generate the results presented in Results, Dopamine innervation to the oPFC is protracted across adolescence, and Figure 1.

Extended Data Figure 2-1. Density estimates of dopamine (TH; TH-immunopositive) varicosities that have been infected with a fluorescent protein-expressing virus for four subregions of the oPFC in adult and early adolescent mice. Varicosity density was estimated by combining the optical fractionator and Cavelieri estimator methods of the software program Stereoinvestigator (see Materials and Methods). These data were used to generate the results presented in Results, Delayed dopamine innervation to the oPFC results from ongoing axon growth, and Figure 2.

Extended Data Figure 3-1. Dopamine (TH-immunopositive) varicosity density estimates in four subregions of the oPFC in adult mice treated with either saline or amphetamine in early adolescence. Varicosity density was estimated by combining the optical fractionator and Cavelieri estimator methods of the software program Stereoinvestigator (see Materials and Methods). These data were used to generate the results presented in Results, Amphetamine in adolescence reduces dopamine varicosity density in the adult oPFC, and Figure 3.

Extended Data Figure 4-1. Dopamine (TH-immunopositive) varicosity density estimates for the piriform cortex in adult and early adolescent mice. Varicosity density was estimated by combining the optical fractionator and Cavelieri estimator methods of the software program Stereoinvestigator (see Materials and Methods). These data were used to generate the results presented in Results, Dopamine innervation to the piriform cortex is not protracted nor influenced by amphetamine in adolescence, and Figure 4B.

Extended Data Figure 4-2. Dopamine (TH-immunopositive) varicosity density estimates for the piriform cortex in adult mice treated with either saline or amphetamine in early adolescence. Varicosity density was estimated by combining the optical fractionator and Cavelieri estimator methods of the software program Stereoinvestigator (see Materials and Methods). These data were used to generate the results presented in Results, Dopamine innervation to the piriform cortex is not protracted nor influenced by amphetamine in adolescence, and Figure 4C. Download Tables, DOCX file.

Results

Dopamine innervation to the oPFC is protracted across adolescence

We found that the density of dopamine varicosities in the oPFC is significantly higher in adult mice compared to adolescent mice, indicating that dopamine innervation continues to increase in the oPFC during adolescence (Fig. 1; Extended Data Fig. 1-1; two-way ANOVA, main effect of age, F(1,18) = 9.904, p = 0.019, no significant effect of region, F(3,18) = 1.30, p = 0.305, or age × region interaction, F(3,18) = 2.47, p = 0.095). Post hoc Hochberg-corrected t tests revealed that dopamine innervation increases during adolescence in the loPFC (t(6) = 3.091, p = 0.021), daiPFC (t(6) = 3.062, p = 0.022), and vaiPFC (t(6) = 6.282, p = 0.0008), but not in the voPFC (t(6) = 1.495, p = 0.186). Visual comparison of densities between adolescence and adulthood in the voPFC (Fig. 1E) indicates that high within-group variability underlies the nonsignificant p value in the voPFC.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Dopamine varicosity density in the oPFC is protracted across adolescence. A, Timeline of experimental procedures; n = 4 per group. B, A micrograph of a coronal section through the frontal cortex of an adult mouse at low magnification (4×) showing the contour of the oPFC. Scale bar = 500 μm. C, A micrograph of a coronal section of the oPFC of an adult mouse at high magnification (60×) showing TH-immunopositive varicosities. Scale bar = 10 μm. D, The voPFC, loPFC, vaiPFC, and daiPFC respectively, are highlighted in increasingly pale shades of purple. Line drawings were derived from Paxinos and Franklin (2013). E, Stereological quantification of dopamine varicosity density reveals that there are more dopamine varicosities in the adult oPFC than the adolescent. Bars represent mean ± standard error (Extended Data >Fig. 1-1).

Delayed dopamine innervation to the oPFC results from ongoing axon growth

The axon-initiated recombination technique we used limits eYFP expression to ventral tegmental area neurons with axons that have reached the NAcc by the start of adolescence (Beier et al., 2015; Reynolds et al., 2017). If the axons of these neurons continue to grow to the oPFC during adolescence, we should observe eYFP-positive dopamine varicosities in the adult oPFC. Remarkably, we find eYFP dopamine varicosities in all four oPFC subregions in adult mice that received dual viral infection in early adolescence (Fig. 2; Extended Data Fig. 2-1). The presence of these varicosities indicates that dopamine axons indeed continue to grow to the oPFC from the NAcc during adolescence. To exclude the possibility that these eYFP-positive dopamine varicosities are collaterals of fibers innervating the NAcc, we performed the same axon-initiated viral tracing experiment in adult mice. eYFP-positive dopamine varicosities in the oPFC are absent or negligible in these mice (Fig. 2; Extended Data Fig. 2-1).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Axons continue to grow to the oPFC during adolescence. A, The dual-viral injection method used to label NAcc-projecting ventral tegmental area neurons with eYFP. B, Timeline of experimental procedures: mice were injected at the start of adolescence (PND22 ± 1) and six weeks later, at which point adolescent mice have reached adulthood, eYFP-expressing dopamine axons in the oPFC were quantified; n = 5. C–E, Micrographs of a coronal section of the oPFC of an adult mouse at high magnification (60×) show (C) TH-immunopositive varicosities, (D) eYFP-expressing varicosities, and (E) an overlay highlighting co-labeled varicosities. Scale bar = 10 μm. F, The voPFC, loPFC, vaiPFC, and daiPFC, respectively, are highlighted in increasingly pale shades of purple. Line drawings were derived from Paxinos and Franklin (2013). G, Stereological quantification of dopamine varicosity density reveals eYFP-expressing dopamine varicosities are present in the oPFC in adult mice that received dual-viral injections in early adolescence (Extended Data Fig. 2-1). H, To ensure the eYFP-expressing dopamine neurons in the oPFC were the result of axon growth and not collaterals, we injected viruses into early adult mice and quantified eYFP-expressing dopamine axons six weeks later; n = 3. I, eYFP-expressing dopamine varicosities are almost entirely absent from the orbital prefrontal cortices of mice that were injected during adulthood (Extended Data Fig. 2-1). G & I, Bars represent mean ± standard error.

Amphetamine in adolescence reduces dopamine varicosity density in the adult oPFC

Amphetamine in adolescence has been found to reduce the number of presynaptic sites from mPFC dopamine axons, measured as a significant reduction in dopamine varicosity density (Reynolds et al., 2015). Here, we measured the density of dopamine varicosities in the oPFC in adult mice exposed to the exact same regimen of amphetamine or saline in adolescence as in Reynolds et al. (2015). Similar to the mPFC, amphetamine in adolescence results in significantly fewer dopamine varicosities in the oPFC (Fig. 3; Extended Data Fig. 3-1; two-way ANOVA, main effect of age, F(1,12) = 15.12, p = 0.008, no significant effect of region, F(2,12) = 0.42, p = 0.670, or age × region interaction, F(2,12) = 3.68, p = 0.057). Post hoc Hochberg-corrected t tests revealed that dopamine varicosities were reduced in the daiPFC (t(6) = 4.987, p = 0.003) and vaiPFC (t(6) = 3.630, p = 0.011), while the effect in the loPFC was marginal (t(6) = 2.370, p = 0.056).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Amphetamine in adolescence alters dopamine connectivity in adulthood. A, Timeline of experimental procedures; n = 4 per group. B, The loPFC, vaiPFC, and daiPFC, respectively, are highlighted in increasingly pale shades of red. Line drawings were derived from Paxinos and Franklin (2013). C, Stereological quantification of dopamine varicosity density reveals that adults exposed to amphetamine during adolescence have about a 40% reduction in dopamine varicosity density in the oPFC compared to saline-treated controls. Bars represent mean ± standard error (Extended Data Fig. 3-1).

Dopamine innervation to the piriform cortex is not protracted nor influenced by amphetamine in adolescence

We measured dopamine varicosity density in the piriform cortex, a cortical region that is not part of the PFC, in adolescent and adult mice. In contrast to the mPFC (Kalsbeek et al., 1988) and oPFC, dopamine varicosity density in the piriform cortex is significantly higher in adolescence compared to adulthood (Fig. 4; Extended Data Fig. 4-1; t(6) = 8.256, p = 0.0002).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Dopamine connectivity in the piriform cortex is not protracted nor influenced by amphetamine in adolescence. A, The piriform cortex was outlined based on Paxinos and Franklin (2013) and is highlighted in green. B, C, Stereological quantification of dopamine varicosity density reveals that (B) early adolescent mice have a significantly higher density of dopamine varicosities in the piriform cortex compared to adults (Extended Data Fig. 4-1) and (C) that amphetamine exposure during adolescence does not alter the density of dopamine varicosities in the piriform cortex. Bars represent mean ± standard error (Extended Data Fig. 4-2).

In addition, amphetamine during adolescence does not alter dopamine varicosity density: levels are similar between adult mice treated with drug or saline in adolescence (Fig. 4; Extended Data Fig. 4-2; t(6) = 0.7985, p = 0.455). This indicates that it is specifically the dopamine innervation to the PFC that is sensitive to amphetamine during adolescence.

Discussion

The increase in mPFC dopamine innervation during adolescence is a well-known phenomenon, both in rodents and primates (Kalsbeek et al., 1988; Rosenberg and Lewis, 1995; Benes et al., 2000; Manitt et al., 2011; Naneix et al., 2012; Reynolds et al., 2017; Willing et al., 2017). However, until now adolescent dopamine innervation in the oPFC remained almost completely unstudied (but see Kalsbeek et al., 1988). Here, we show that in mice the dopamine innervation to the oPFC is still maturing during adolescence. Specifically, oPFC dopamine varicosity density increases during this period. Critically, this increase is due to the growth of new axons to the oPFC. Because oPFC dopamine axons are still growing, they remain vulnerable to environmental influences for an extended spatiotemporal window. We find that exposure to amphetamine during adolescence reduces the number of dopamine varicosities in the oPFC in adulthood. Notably, these effects appear to be specific to the PFC; we do not find them in the adjacent piriform cortex.

Although we discuss our findings in the context of the relevant literature, we note that the matter of PFC homology between the rodent and primate is not yet settled (Carlén, 2017). However, available evidence strongly supports homology between the rodent and primate oPFC (Uylings et al., 2003; Heilbronner et al., 2016; Izquierdo, 2017). Finally, homology between the primate and rodent oPFC would imply that the oPFC is homologous among rodents, however to our knowledge there are no studies directly examining this. Therefore, we encourage caution in translating our findings to other rodents, including rats.

The Netrin-1 receptor DCC (deleted in colorectal cancer) is responsible for coordinating dopamine axon structure and function in the mPFC (Hoops and Flores, 2017). Reducing DCC expression on ventral tegmental neurons in adolescence induces structural deficiencies in mPFC dopamine axons (Reynolds et al., 2017), and amphetamine in adolescence reduces DCC expression on these neurons (Yetnikoff et al., 2010, 2011). These alterations result in persistent cognitive changes in adulthood (Reynolds et al., 2015). Our results suggest that amphetamine in adolescence is reducing DCC expression on ventral tegmental dopamine neurons that project to the oPFC, resulting in denuded dopamine axons in this region. Furthermore, since the vast majority of dopamine varicosities form synapses (Séguéla et al., 1988), the reduction we see in varicosities in amphetamine-treated mice suggests that dopamine axons are forming far fewer synapses in the oPFC as compared to mice treated with saline. Therefore, our results suggest that the growing dopamine axons are vulnerable to environmental influences and that amphetamine exposure during adolescence may impair the formation of dopamine synapses onto their target cells within the oPFC.

The piriform cortex, part of the mammalian olfactory cortex, is structurally and functionally linked to the oPFC in rodents and humans (Gottfried et al., 2003; Uylings et al., 2003; Fuster, 2015) and in rodents receives about the same density of dopamine input as the oPFC (Fallon and Loughlin, 1987). However, unlike the oPFC, the piriform cortex matures relatively early in human postnatal development (Gogtay et al., 2004; Shaw et al., 2008), as do piriform cortex-dependent olfactory discrimination behaviors in rodents (Staubli et al., 1987; Hu et al., 1997). Therefore, the piriform cortex was an ideal cortical region to use to examine whether our results are specific to the PFC or reflect general trends in frontal cortex development. To our knowledge, this is the first time that the postnatal developmental time course of the dopamine innervation to the piriform cortex has been studied, and so we feel that our findings in this region are also important in their own right. We find that adolescent mice had a higher density of dopamine varicosities compared to adult mice, the opposite pattern to the one we observed in the oPFC. However, this result is in line with what is observed in the cortex as a whole, where there is an overproduction of synapses during early adolescence followed by a period of rapid pruning in primates and rodents (Lidow et al., 1991; Andersen, 2003; Crews et al., 2007; Juraska and Willing, 2017). In fact, it has been estimated that in primates as many as 30 000 synapses may be lost per second over the entire cortex during adolescence, resulting in an overall loss of up to one half the total number of synapses present during early adolescence (Rakic et al., 1994). Our findings are also in line with a study that found dopamine receptor expression in the rat piriform cortex peaks in adolescence before declining in adulthood (Garske et al., 2013). Therefore, axon growth and synapse formation during adolescence appears to be a unique characteristic of the mesocortical dopamine projections to the PFC.

Conclusion

Taken together, our results show that dopamine development to the oPFC is delayed across adolescence. Importantly, we have found that this delayed growth is due to axons that previously innervated the NAcc leaving this region and growing to the oPFC during this period. Furthermore, we show that these axons are vulnerable to environmental influences such as exposure to addictive drugs. Amphetamine exposure during early adolescence results in reduced synapse formation in the oPFC. Finally, dopamine innervation to the piriform cortex reaches adult densities before adolescence, indicating that delayed growth of dopamine axons, and the associated vulnerability to environmental influences, is specific to the PFC.

Footnotes

  • The authors declare no competing financial interests.

  • This work was supported by National Institute on Drug Abuse Grants R01DA037911 (to C.F.) and F31DA041188 (to L.M.R.), the Natural Science and Engineering Research Council of Canada Grant 2982226 (to C.F.), the Canadian Institutes of Health Research Grant MOP-74709 (to C.F.), and the Quebec Nature and Technology Research Fund Grant 208332 (to D.H.). C.F. is a research scholar of the Fonds de Recherche du Québec-Santé.

This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    Andersen SL (2003) Trajectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27:3–18. pmid:12732219
    OpenUrlCrossRefPubMed
  2. ↵
    Änggård E, Gunne LM, Jönsson LE, Niklasson F (1970) Pharmacokinetic and clinical studies on amphetamine dependent subjects. Eur J Clin Pharmacol 3:3–11.
    OpenUrl
  3. ↵
    Anggård E, Gunne LM, Niklasson F (1970) Gas chromatographic determination of amphetamine in blood, tissue, and urine. Scand J Clin Lab Invest 26:137–143. doi:10.3109/00365517009049225 pmid:5472590
    OpenUrlCrossRefPubMed
  4. ↵
    Bari A, Robbins TW (2013) Inhibition and impulsivity: behavioral and neural basis of response control. Prog Neurobiol 108:44–79. doi:10.1016/j.pneurobio.2013.06.005 pmid:23856628
    OpenUrlCrossRefPubMed
  5. ↵
    Beier KT, Steinberg EE, DeLoach KE, Xie S, Miyamichi K, Schwarz L, Gao XJ, Kremer EJ, Malenka RC, Luo L (2015) Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping. Cell 162:622–634. doi:10.1016/j.cell.2015.07.015 pmid:26232228
    OpenUrlCrossRefPubMed
  6. ↵
    Benes FM, Vincent SL, Molloy R, Khan Y (1996) Increased interaction of dopamine‐immunoreactive varicosities with GABA neurons of rat medial prefrontal cortex occurs during the postweanling period. Synapse 23:237–245. doi:10.1002/(SICI)1098-2396(199608)23:4<237::AID-SYN1>3.0.CO;2-8 pmid:8855508
    OpenUrlCrossRefPubMed
  7. ↵
    Benes FM, Taylor JB, Cunningham MC (2000) Convergence and plasticity of monoaminergic systems in the medial prefrontal cortex during the postnatal period: implications for the development of psychopathology. Cereb Cortex 10:1014–1027. pmid:11007552
    OpenUrlCrossRefPubMed
  8. ↵
    Berger B, Tassin JP, Blanc G, Moyne MA, Thierry AM (1974) Histochemical confirmation for dopaminergic innervation of the rat cerebral cortex after destruction of the noradrenergic ascending pathways. Brain Res 81:332–337. pmid:4373130
    OpenUrlCrossRefPubMed
  9. ↵
    Berger B, Verney C, Gay M, Vigny A (1983) Immunocytochemical characterization of the dopaminergic and noradrenergic innervation of the rat neocortex during early ontogeny. Prog Brain Res 58:263–267.
    OpenUrlPubMed
  10. ↵
    Bru T, Salinas S, Kremer EJ (2010) An update on canine adenovirus type 2 and its vectors. Viruses 2:2134–2153. doi:10.3390/v2092134 pmid:21994722
    OpenUrlCrossRefPubMed
  11. ↵
    Caballero A, Granberg R, Tseng KY (2016) Mechanisms contributing to prefrontal cortex maturation during adolescence. Neurosci Biobehav Rev 70:4–12. doi:10.1016/j.neubiorev.2016.05.013 pmid:27235076
    OpenUrlCrossRefPubMed
  12. ↵
    Carlén M (2017) What constitutes the prefrontal cortex? Science 358:478–482. doi:10.1126/science.aan8868 pmid:29074767
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Casey BJ, Jones RM, Hare TA (2008) The adolescent brain. Ann NY Acad Sci 1124:111–126. doi:10.1196/annals.1440.010 pmid:18400927
    OpenUrlCrossRefPubMed
  14. ↵
    Crews FT, He J, Hodge C (2007) Adolescent cortical development: a critical period of vulnerability for addiction. Pharmacol Biochem Behav 86:189–199. doi:10.1016/j.pbb.2006.12.001
    OpenUrlCrossRefPubMed
  15. ↵
    Daubaras M, Dal Bo G, Flores C (2014) Target-dependent expression of the netrin-1 receptor, UNC5C, in projection neurons of the ventral tegmental area. Neuroscience 260:36–46. doi:10.1016/j.neuroscience.2013.12.007
    OpenUrlCrossRefPubMed
  16. ↵
    Doremus-Fitzwater TL, Spear LP (2016) Reward-centricity and attenuated aversions: an adolescent phenotype emerging from studies in laboratory animals. Neurosci Biobehav Rev 70:121–134. doi:10.1016/j.neubiorev.2016.08.015 pmid:27524639
    OpenUrlCrossRefPubMed
  17. ↵
    Fallon JH, Loughlin SE (1987) Monoamine innervation of cerebral cortex and a theory of the role of monoamines in cerebral cortex and basal ganglia. Cereb Cortex 6:41–127.
    OpenUrl
  18. ↵
    Feldpausch DL, Needham LM, Stone MP, Althaus JS, Yamamoto BK, Svensson KA, Merchant KM (1998) The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. J Pharmacol Exp Ther 286:497–508. pmid:9655895
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Fuster JM (2015) The prefrontal cortex, Ed 5. San Diego: Elsevier.
  20. ↵
    Garske AK, Lawyer CR, Peterson BM, Illig KR (2013) Adolescent changes in dopamine D1 receptor expression in orbitofrontal cortex and piriform cortex accompany an associative learning deficit. PLoS One 8:e56191.
    OpenUrlCrossRefPubMed
  21. ↵
    Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF, Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sie USA 101:8174–8179. doi:10.1073/pnas.0402680101
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Goldstein RZ, Volkow ND (2011) Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12:652–669. doi:10.1038/nrn3119
    OpenUrlCrossRefPubMed
  23. ↵
    Gottfried JA, O'Doherty J, Dolan RJ (2003) Encoding predictive reward value in human amygdala and orbitofrontal cortex. Science 301:1104–1107. doi:10.1126/science.1087919 pmid:12934011
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Gourley SL, Taylor JR (2016) Going and stopping: dichotomies in behavioral control by the prefrontal cortex. Nat Neurosci 19:656–664. doi:10.1038/nn.4275
    OpenUrlCrossRefPubMed
  25. ↵
    Gustavsen I, Mørland J, Bramness JG (2006) Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers. Accid Anal Prev 38:490–495. doi:10.1016/j.aap.2005.11.005 pmid:16343411
    OpenUrlCrossRefPubMed
  26. ↵
    Haycock JW (1987) Stimulation-dependent phosphorylation of tyrosine hydroxylase in rat corpus striatum. Brain Res Bull 19:619–622. doi:10.1016/0361-9230(87)90046-3
    OpenUrlCrossRefPubMed
  27. ↵
    Heilbronner SR, Rodriguez-Romaguera J, Quirk GJ, Groenewegen HJ, Haber SN (2016) Circuit-based corticostriatal homologies between rat and primate. Biol Psych 80:509–521. doi:10.1016/j.biopsych.2016.05.012
    OpenUrlCrossRefPubMed
  28. ↵
    Hochberg Y (1988) A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800–802. doi:10.1093/biomet/75.4.800
    OpenUrlCrossRef
  29. ↵
    Hoops D, Flores C (2017) Making dopamine connections in adolescence. Trends Neurosci 40:709–719.
    OpenUrl
  30. ↵
    Hu D, Griesbach G, Amsel A (1997) Development of vicarious trial-and-error behavior in odor discrimination learning in the rat: relation to hippocampal function? Behav Brain Res 86:67–70. pmid:9105583
    OpenUrlCrossRefPubMed
  31. ↵
    Izquierdo A (2017) Functional heterogeneity within rat orbitofrontal cortex in reward learning and decision making. J Neurosci 37:10529–10540. doi:10.1523/JNEUROSCI.1678-17.2017 pmid:29093055
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Juraska JM, Willing J (2017) Pubertal onset as a critical transition for neural development and cognition. Brain Res 1654:87–94. doi:10.1016/j.brainres.2016.04.012
    OpenUrlCrossRef
  33. ↵
    Kalsbeek A, Voorn P, Buijs RM, Pool CW, Uylings HBM (1988) Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp Neur 269:58–72. doi:10.1002/cne.902690105 pmid:3361004
    OpenUrlCrossRefPubMed
  34. ↵
    Kang S, Wu MM, Galvez R, Gulley JM (2016) Timing of amphetamine exposure in relation to puberty onset determines its effects on anhedonia, exploratory behavior, and dopamine D1 receptor expression in young adulthood. Neuroscience 339:72–84. doi:10.1016/j.neuroscience.2016.09.044
    OpenUrlCrossRef
  35. ↵
    Kolb B (2006) Do all mammals have a prefrontal cortex? In: Evolution of nervous systems: a comprehensive reference; four-volume set, pp 443–450. San Diego: Academic Press.
  36. ↵
    Kramer JC, Fischman VS, Littlefield DC (1967) Amphetamine abuse: pattern and effects of high doses taken intravenously. JAMA 201:305–309. pmid:6071725
    OpenUrlCrossRefPubMed
  37. ↵
    Kuczenski R, Segal DS (2005) Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse. Biol Psych 57:1391–1396. doi:10.1016/j.biopsych.2004.12.036
    OpenUrlCrossRefPubMed
  38. ↵
    Levitt P, Moore RY (1979) Development of the noradrenergic innervation of neocortex. Brain Res 162:243–259. pmid:761089
    OpenUrlCrossRefPubMed
  39. ↵
    Lidow MS, Goldman-Rakic PS, Rakic P (1991) Synchronized overproduction of neurotransmitter receptors in diverse regions of the primate cerebral cortex. Proc Natl Acad Sie USA 88:10218–10221. doi:10.1073/pnas.88.22.10218
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Luna B, Marek S, Larsen B, Tervo-Clemmens B, Chahal R (2015) An integrative model of the maturation of cognitive control. Annu Rev Neurosci 38:151–170. doi:10.1146/annurev-neuro-071714-034054 pmid:26154978
    OpenUrlCrossRefPubMed
  41. ↵
    Manitt C, Mimee A, Eng C, Pokinko M, Stroh T, Cooper HM, Kolb B, Flores C (2011) The netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J Neurosci 31:8381–8394. doi:10.1523/JNEUROSCI.0606-11.2011 pmid:21653843
    OpenUrlAbstract/FREE Full Text
  42. ↵
    Manitt C, Eng C, Pokinko M, Ryan RT, Torres-Berrío A, Lopez JP, Yogendran SV, Daubaras MJJ, Grant A, Schmidt ERE, Tronche F, Krimpenfort P, Cooper HM, Pasterkamp RJ, Kolb B, Turecki G, Wong TP, Nestler EJ, Giros B, Flores C (2013) dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients. Transl Psychiatry 3:e338–e313. doi:10.1038/tp.2013.105 pmid:24346136
    OpenUrlCrossRefPubMed
  43. ↵
    Miner LH, Schroeter S, Blakely RD, Sesack SR (2003) Ultrastructural localization of the norepinephrine transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to probable dopamine terminals. J Comp Neur 466:478–494. doi:10.1002/cne.10898 pmid:14566944
    OpenUrlCrossRefPubMed
  44. ↵
    Naneix F, Marchand AR, Di Scala G, Pape JR, Coutureau E (2012) Parallel maturation of goal-directed behavior and dopaminergic systems during adolescence. J Neurosci 32:16223–16232. doi:10.1523/JNEUROSCI.3080-12.2012 pmid:23152606
    OpenUrlAbstract/FREE Full Text
  45. ↵
    Parish CL, Stanic D, Drago J, Borrelli E, Finkelstein DI, Horne MK (2002) Effects of long‐term treatment with dopamine receptor agonists and antagonists on terminal arbor size. Eur J Neurosci 16:787–794. pmid:12372014
    OpenUrlCrossRefPubMed
  46. ↵
    Paus T (2005) Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci 9:60–68. doi:10.1016/j.tics.2004.12.008
    OpenUrlCrossRefPubMed
  47. ↵
    Paxinos G, Franklin KBJ (2013) The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
  48. ↵
    Pellis S, Pellis V (2013) The playful brain. London: Oneworld Publications.
  49. ↵
    Pickel VM, Joh TH, Field PM, Becker CG, Reis DJ (1975) Cellular localization of tyrosine hydroxylase by immunohistochemistry. J Histochem Cytochem 23:1–12. doi:10.1177/23.1.234988 pmid:234988
    OpenUrlCrossRefPubMed
  50. ↵
    Preuss TM (1995) Do rats have prefrontal cortex? The rose-woolsey-akert program reconsidered. J Cogn Neurosci 7:1–24. doi:10.1162/jocn.1995.7.1.1 pmid:23961750
    OpenUrlCrossRefPubMed
  51. ↵
    Rakic P, Bourgeois J-P, Goldman-Rakic PS (1994) Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness. Prog Brain Res 102:227–243.
    OpenUrlCrossRefPubMed
  52. ↵
    Ranganath A, Jacob SN (2016) Doping the mind: dopaminergic modulation of prefrontal cortical cognition. Neuroscientist 22:593–603. doi:10.1177/1073858415602850 pmid:26338491
    OpenUrlCrossRefPubMed
  53. ↵
    Reynolds LM, Makowski CS, Yogendran SV, Kiessling S, Cermakian N, Flores C (2015) Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a dcc-dependent manner. Neuropsychopharmacology 40:1101–1112. doi:10.1038/npp.2014.287
    OpenUrlCrossRefPubMed
  54. ↵
    Reynolds LM, Pokinko M, Torres-Berrío A, Cuesta S, Lambert LC, Del Cid Pellitero E, Wodzinski M, Manitt C, Krimpenfort P, Kolb B, Flores C (2017) DCC receptors drive prefrontal cortex maturation by determining dopamine axon targeting in adolescence. Biol Psych 83:181–192.
    OpenUrl
  55. ↵
    Riffee WH, Ludden TM, Wilcox RE, Gerald MC (1978) Brain and plasma concentrations of amphetamine isomers in mice. J Pharmacol Exp Ther 206:586–594. pmid:702323
    OpenUrlAbstract/FREE Full Text
  56. ↵
    Rosenberg DR, Lewis DA (1995) Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices - a tyrosine-hydroxylase immunohistochemical analysis. J Comp Neur 358:383–400. doi:10.1002/cne.903580306 pmid:7560293
    OpenUrlCrossRefPubMed
  57. ↵
    Schoenbaum G, Roesch MR, Stalnaker TA (2006) Orbitofrontal cortex, decision-making and drug addiction. Trends Neurosci 29:116–124. doi:10.1016/j.tins.2005.12.006 pmid:16406092
    OpenUrlCrossRefPubMed
  58. ↵
    Séguéla P, Watkins KC, Descarries L (1988) Ultrastructural features of dopamine axon terminals in the anteromedial and the suprarhinal cortex of adult rat. Brain Res 442:11–22. pmid:3359247
    OpenUrlCrossRefPubMed
  59. ↵
    Shaw PW, Kabani NJ, Lerch JP, Eckstrand K, Lenroot R, Gogtay N, Greenstein D, Clasen L, Evans A, Rapoport JL, Giedd JN, Wise SP (2008) Neurodevelopmental trajectories of the human cerebral cortex. J Neurosci 28:3586–3594. doi:10.1523/JNEUROSCI.5309-07.2008
    OpenUrlAbstract/FREE Full Text
  60. ↵
    Staubli U, Schottler F, Nejat-Bina D (1987) Role of dorsomedial thalamic nucleus and piriform cortex in processing olfactory information. Behav Brain Res 25:117–129. pmid:3675824
    OpenUrlCrossRefPubMed
  61. ↵
    Sturman DA, Moghaddam B (2011) The neurobiology of adolescence: changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci Biobehav Rev 35:1704–1712. doi:10.1016/j.neubiorev.2011.04.003 pmid:21527288
    OpenUrlCrossRefPubMed
  62. ↵
    Uylings HBM, Groenewegen HJ, Kolb B (2003) Do rats have a prefrontal cortex? Behav Brain Res 146:3–17. pmid:14643455
    OpenUrlCrossRefPubMed
  63. ↵
    Van Eden CG, Hoorneman EM, Buijs RM, Matthijssen MA, Geffard M, Uylings HBM (1987) Immunocytochemical localization of dopamine in the prefrontal cortex of the rat at the light and electron microscopical level. Neurosci 22:849–862. doi:10.1016/0306-4522(87)92964-2
    OpenUrlCrossRefPubMed
  64. ↵
    Van Swearingen AED, Walker QD, Kuhn CM (2013) Sex differences in novelty- and psychostimulant-induced behaviors of C57BL/6 mice. Psychopharmacology 225:707–718. doi:10.1007/s00213-012-2860-4 pmid:22975726
    OpenUrlCrossRefPubMed
  65. ↵
    Verney C, Berger B, Adrien J, Vigny A, Gay M (1982) Development of the dopaminergic innervation of the rat cerebral cortex. A light microscopic immunocytochemical study using anti-tyrosine hydroxylase antibodies. Dev Brain Res 5:41–52. doi:10.1016/0165-3806(82)90111-0
    OpenUrlCrossRef
  66. ↵
    Willing J, Cortes LR, Brodsky JM, Kim T, Juraska JM (2017) Innervation of the medial prefrontal cortex by tyrosine hydroxylase immunoreactive fibers during adolescence in male and female rats. Dev Psychobiol 59:583–589. doi:10.1002/dev.21525 pmid:28561889
    OpenUrlCrossRefPubMed
  67. ↵
    Wilson RC, Takahashi YK, Schoenbaum G, Niv Y (2014) Orbitofrontal cortex as a cognitive map of task space. Neuron 81:267–279. doi:10.1016/j.neuron.2013.11.005 pmid:24462094
    OpenUrlCrossRefPubMed
  68. ↵
    Wise SP (2008) Forward frontal fields: phylogeny and fundamental function. Trends Neurosci 31:599–608. doi:10.1016/j.tins.2008.08.008 pmid:18835649
    OpenUrlCrossRefPubMed
  69. ↵
    Ye T, Pozos H, Phillips TJ, Izquierdo A (2014) Long-term effects of exposure to methamphetamine in adolescent rats. Drug Alcohol Depend 138:17–23. doi:10.1016/j.drugalcdep.2014.02.021 pmid:24629630
    OpenUrlCrossRefPubMed
  70. ↵
    Yetnikoff L, Eng C, Benning S, Flores C (2010) Netrin-1 receptor in the ventral tegmental area is required for sensitization to amphetamine. Eur J Neurosci 31:1292–1302. doi:10.1111/j.1460-9568.2010.07163.x pmid:20345916
    OpenUrlCrossRefPubMed
  71. ↵
    Yetnikoff L, Almey A, Arvanitogiannis A, Flores C (2011) Abolition of the behavioral phenotype of adult netrin-1 receptor deficient mice by exposure to amphetamine during the juvenile period. Psychopharmacology 217:505–514. doi:10.1007/s00213-011-2312-6 pmid:21523346
    OpenUrlCrossRefPubMed

Synthesis

Reviewing Editor: Karen Szumlinski, University of California at Santa Barbara

Decisions are customarily a result of the Reviewing Editor and the peer reviewers coming together and discussing their recommendations until a consensus is reached. When revisions are invited, a fact-based synthesis statement explaining their decision and outlining what is needed to prepare a revision will be listed below. The following reviewer(s) agreed to reveal their identity: David Moorman.

Following consultation with two expert reviewers, we have come to the decision of “Revise and Re-review” for your article. This decision was based on the enthusiasm we all have for the significance of the topic of study, but concerns over the Methods and Results as currently written. None of the revisions should require more than two months' work. The specific comments of the reviewers are listed below:

Reviewer 1:

Major:

I take issue with description throughout as 'prefrontal cortex' and the loose/interchangeable citation of primate and rodent literature. Rodents do not have a granular PFC. There is indeed controversy about homology (see Preuss, 1995; Wise, 2008) though OFC may be safer to make such claims as being within PFC. For example, connectivity-based inferences about OFC-striatum homology between primate and rodent are supported by recent literature (see Heilbronner et al. Biol Psychiatry 2016 and recent commentary by Izquierdo, 2017 in J Neurosci). Suggest referring to as frontal cortex or OFC, or to make much more clear as referring to 'mouse orbitofrontal cortex.'

Similarly, the title should be more informative that this is mouse orbitofrontal cortex that is being studied.

There is poor detail about surgical procedures in the young animals. Were there special stereotaxic procedures for an animal of that size? There are no details on anesthesia, analgesics, for the axon tracking surgeries where virus is injected in the brain. Please provide.

The effects reported here are more pronounced in certain subregions of OFC over others, an interesting finding that is not emphasized, and may speak to functional heterogeneity within rodent OFC (Izquierdo, 2017). For example, authors found that dopamine innervation increases during adolescence in the lateral OFC, dorsal AI, and ventral AI, but not ventral OFC. Authors maintain that this is because ventral OFC is located adjacent to the dorsal striatum and that fibers from NAcc to OFC run anteriodorsally through dorsal striatum and forceps minor. Is there any other anatomical evidence of this proposed mechanism? Please clarify. Additionally, it is interesting that dopamine innervation at more anterior levels (and consequently medial subregion) is very low/absent. It is not clear to me what the authors make of it; there may be functional (behavioral) consequences following developmental amphetamine exposure because of this, but it is not discussed.

Lines 265-266 “until now adolescent dopamine development in the oPFC remained almost completely unstudied...” This seems overstated since different groups have looked at other markers of dopamine development, such as dopamine receptor density and expression in rodent frontal cortex in adolescent development (Tarazi & Baldessarini, 2000; Garske et al. 2013).

Some mention of how much of these findings in mouse may be translated to rat (not just primate) would also be welcome.

Minor comments:

Lines 33-34 of Abstract- do the authors mean to say instead that amphetamine impacts dopamine development in adolescence uniquely in PFC?

Lines 95-97- the dosing regimen of amphetamine was chosen to achieve a blood plasma concentration in rodents that is similar to that of recreational intake of amphetamine in human adolescents. What is this dose? and was it confirmed here in the present study via blood collection?

Lines 313-315, “this is the first time that the postnatal developmental time course of the dopamine projection to the piriform cortex has been studied.” But authors later cite Garske et al. 2013 that studied OFC and piriform cortex in adolescence.

Line 91, regimen

Reviewer 2:

1. The phrasing of “growth of dopamine axons from the nucleus accumbens” or a variant is used throughout the manuscript. This is confusing because it sounds like the authors are saying that dopamine, originating in the NAcc, is going to the OFC. This should be changed to clarify.

2. The authors argue that TH staining in OFC is not due to noradrenergic inputs from the locus coeruleus. They cite a number of papers showing limited colocalization between NET and TH, indicating that TH staining primarily identifies dopaminergic axons. However, at least one cited paper (Verney et al., 1982) discuss a population of TH-immunoreactive fibers that disappear after lesioning of the locus coeruleus, indicating that there may be some detection of noradrenergic fibers. This should be considered thoroughly as the manuscript depends on TH immunohistochemistry reflecting dopamine.

3. Figure 1D should show regions analyzed in a color-coded fashion. I also don't see where VO is marked on the anatomy figure. The specific details of anatomical demarcations could be cleared up.

4. Can CAV enter axons through en passant boutons? If so, is there any concern that the use of CAV in the NAcc is labeling fibers that project through the NAcc?

5. In the discussion, the authors state that adult levels were reached in voPFC prior to the onset of adolescence. This isn't clear from figure 1, where the difference between adolescent and adult density is similar in voPFC the other regions, and that there is an increase between adolescence and adults. Is this a real difference or an artifact of statistical analysis on very small numbers?

6. Related to 5, there is a decent amount of speculation in the discussion about why there is no statistical difference in voPFC. None of this is based on much evidence. The finding that there are TH+/eYFP+ fibers in adult voPFC as supporting evidence was confusing to me.

7. Is there a linear relationship between dopamine varicosities and axons? If so, this should be noted somewhere (unless I missed it). If not, much of the framing of the discussion should be rewritten, given that the study measured varicosities and the authors use this information to make claims about axonal presence and structure.

8. Is there a significant difference between saline treated animals in figure 3C and adult animals in figure 1D? There are differences, and if any of these are significant, it potentially undermines the intended comparisons (adolescent vs. adult or saline vs. amphetamine), given that all comparisons are across-subject.

Back to top

In this issue

eneuro: 5 (1)
eNeuro
Vol. 5, Issue 1
January/February 2018
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence
Daniel Hoops, Lauren M. Reynolds, Jose-Maria Restrepo-Lozano, Cecilia Flores
eNeuro 9 January 2018, 5 (1) ENEURO.0372-17.2017; DOI: 10.1523/ENEURO.0372-17.2017

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence
Daniel Hoops, Lauren M. Reynolds, Jose-Maria Restrepo-Lozano, Cecilia Flores
eNeuro 9 January 2018, 5 (1) ENEURO.0372-17.2017; DOI: 10.1523/ENEURO.0372-17.2017
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Conclusion
    • Footnotes
    • References
    • Synthesis
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • drug use
  • guidance cue
  • orbitofrontal cortex
  • piriform cortex

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • A Very Fast Time Scale of Human Motor Adaptation: Within Movement Adjustments of Internal Representations during Reaching
  • TrkB Signaling Influences Gene Expression in Cortistatin-Expressing Interneurons
  • Optogenetic Activation of β-Endorphin Terminals in the Medial Preoptic Nucleus Regulates Female Sexual Receptivity
Show more New Research

Disorders of the Nervous System

  • Parallel gene expression changes in ventral midbrain dopamine and GABA neurons during normal aging
  • Demyelination produces a shift in the population of cortical neurons that synapse with callosal oligodendrocyte progenitor cells
  • Syngap+/- CA1 pyramidal neurons exhibit upregulated translation of long mRNAs associated with LTP
Show more Disorders of the Nervous System

Subjects

  • Disorders of the Nervous System
  • Home
  • Alerts
  • Follow SFN on BlueSky
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Notice
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2025 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.